$CEVA (CEVA Inc.)

$CEVA {{ '2016-02-23T12:55:13+0000' | timeago}} • Announcement

Licensor of signal processing IP $CEVA and Spreadtrum Communications, a Chinese fabless semiconductor company, announced the expansion of their long-term partnership around Spreadtrum's latest 64-bit Octa-Core LTE SoC, the SC9860 smartphone platforms. This platform integrates multiple CEVA DSPs performing multiple signal processing workloads.

$MSI {{ '2018-01-18T20:46:09+0000' | timeago}} • Announcement

$MSI signed a contract with the Ministry of Internal Affairs of the Republic of Moldova for the expansion of their mission-critical TETRA communications network. Within the framework of the contract, $MSI will extend the existing TETRA digital radio network and build a nationwide TETRA network for the Moldovan police.

$MSCC {{ '2018-01-16T17:37:50+0000' | timeago}} • Announcement

$MSCC said its products, including its field programmable gate arrays (FPGAs), are not affected by the recently identified security flaws associated with the use of x86 and ARM and a number of other processors. Security researchers revealed major computer chip vulnerabilities, called Spectre and Meltdown, in chips were affecting devices globally.

$SNPS {{ '2018-01-11T14:29:11+0000' | timeago}} • Announcement

$SNPS announced the formation of a Technical Advisory Board (TAB) to guide the technical direction of the Synopsys Software Integrity Group's security products and services, foster innovation and help ensure long-term business success. The TAB will be chaired by Gary McGraw, VP of security technology at Synopsys.

$SNPS {{ '2018-01-11T13:20:13+0000' | timeago}} • Announcement

$SNPS acquired Kilopass Technology, Inc., a provider of antifuse one-time programmable non-volatile memory IP used in automotive, mobile, industrial, and Internet of Things applications. The terms of the deal were not disclosed.

$MRK {{ '2018-01-09T20:27:32+0000' | timeago}} • Announcement

Pharma company $MRK said the FDA has granted 'Breakthrough Therapy Designation' for Lenvima, a multiple receptor tyrosine kinase inhibitor developed by Eisai in combination with Merck's anti-PD-1 therapy Keytruda for the treatment of renal cell carcinoma. The FDA action was based on the results of a multi-center study conducted in US and Europe.

$MRK {{ '2018-01-09T18:45:44+0000' | timeago}} • Announcement

Merck today announced that it has received Breakthrough Therapy Designation from FDA for LENVIMA and KEYTRUDA. The combination therapy (LENVIMA & KEYTRUDA) is being jointly developed by Eisai and $MRK for treating patients with advanced and/or metastatic renal cell carcinoma. In 2017, approx. 63,990 new cases were estimated to have occurred in US.

$LFUS {{ '2018-01-05T14:53:08+0000' | timeago}} • Announcement

$LFUS and $IXYS announced the election deadline by which $IXYS stockholders of record may elect to receive cash, shares of $LFUS common stock or both as merger consideration in connection with the $LFUS acquisition of $IXYS. The election deadline is Jan. 12, 2018. The parties expect to close the transaction on Jan. 17, 2018.

$KOPN {{ '2018-01-05T13:17:05+0000' | timeago}} • Announcement

$KOPN and Pico Interactive have partnered to showcase a new jointly developed wearable device, called Eagle, that enables a home theater entertainment experience on the go. The Eagle is a lightweight mobile headset featuring over-ear noise cancelling headphones and a removable high-definition OLED display band.

$MRK {{ '2018-01-02T20:34:14+0000' | timeago}} • Announcement

Merck announced today that Japanese Ministry of Health, Labor and Welfare (MHLW) has approved its cancer drug KEYTRUDA for treating patients with Urothelial Carcinoma, a type of bladder cancer. This approval helps $MRK to market KEYTRUDA for 4 types of cancer in Japan. The company plans to market KEYTRUDA in partnership with Taiho Pharmaceuticals.

$PFE {{ '2017-12-26T12:25:28+0000' | timeago}} • Announcement

$PFE and $MRK announced that the US FDA has approved STEGLATRO (ertugliflozin) tablets, an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor, and the fixed-dose combination STEGLUJAN (ertugliflozin and sitagliptin) tablets for adults with type 2 diabetes.

$MRK {{ '2017-12-22T16:34:34+0000' | timeago}} • Announcement

$MRK and $PFE announced that the FDA approved STEGLATROTM (ertugliflozin) tablets, an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor, and the fixed-dose combination STEGLUJAN (ertugliflozin and sitagliptin) tablets.

$CAMP {{ '2017-12-21T21:21:32+0000' | timeago}} • Announcement

Including the $13MM estimated gain from the expected receipt of the third installment of the legal settlement with a former LoJack battery supplier, $CAMP now sees revenues of $91-96MM with net income of $0.23-0.32 per diluted share for 4Q18.

$CAMP {{ '2017-12-21T21:19:07+0000' | timeago}} • Announcement

As $CAMP received $13MM of net proceeds from a legal settlement with a former LoJack battery supplier, the telematics company posted a net income of $11.8MM or $0.33 per diluted share in 3Q18, vs. last year's loss of $1.5MM or $0.04 per share. Consolidated revenue jumped 12% to $93.7MM in the quarter.

$KOPN {{ '2017-12-14T22:01:37+0000' | timeago}} • Announcement

$KOPN, a provider of wearable technologies, appointed Tom Futch as SVP of Sales and Marketing for its Solos smart glass business. Futch has more than two decades’ experience leading global sales, marketing and branding strategy for leading fitness wearables and apps. He will be reporting to President and CEO John Fan.

$CCMP {{ '2017-12-12T13:58:24+0000' | timeago}} • Announcement

$CCMP appointed Scott Beamer as VP and CFO. He will succeed William Johnson, who plans to retire after almost 15 years as CFO of the company. Beamer will assume his role as VP and CFO on Jan. 15, 2018. Johnson will remain with the company for a period of time to assist with a smooth transition.

$CCMP {{ '2017-12-12T13:41:08+0000' | timeago}} • Announcement

$CCMP has declared a quarterly cash dividend of $0.20 per share on its common stock. The dividend will be payable on or about Jan 30, 2018 to shareholders as on Dec 22, 2017.

$SNPS {{ '2017-12-12T13:32:19+0000' | timeago}} • Announcement

$SNPS completed its acquisition of Black Duck Software Inc., a privately-held leader in automated solutions for securing and managing open source software. The value of the cash transaction was about $547MM net of cash acquired.

$MRK {{ '2017-12-11T14:15:30+0000' | timeago}} • Announcement

Merck said today that the FDA has given consent to review a supplemental Biologics License Application (sBLA) for KEYTRUDA for the treatment of relapsed or refractory primary mediastinal large B-cell lymphoma (PMBCL), a type of non-Hodgkin lymphoma. FDA has granted $MRK Priority Review status and expected to complete evaluation by April 3, 2018.

$SNPS {{ '2017-12-07T18:03:32+0000' | timeago}} • Announcement

$SNPS has entered into accelerated share repurchase agreements (ASRs) with JPMorgan Chase Bank, National Association and MUFG Securities EMEA plc. to repurchase a total of $200MM of $SNPS stock. $SNPS will receive an aggregate initial share delivery of approx. 1.8MM shares, with the remainder to be settled on or before May 16, 2018.

$IPGP {{ '2017-12-04T15:58:50+0000' | timeago}} • Announcement

$IPGP acquired Laser Depth Dynamics, provider of in-process quality monitoring for laser-based welding applications. Terms of the acquisition were not disclosed.

Recent Transcripts

LIVE (Live Ventures Incorporated)
Wednesday, December 27 2017 - 9:30pm
CAMP (CalAmp Corp.)
Thursday, December 21 2017 - 9:30pm
SNPS (Synopsys Inc.)
Wednesday, November 29 2017 - 10:00pm
ASYS (Amtech Systems Inc)
Monday, November 20 2017 - 10:00pm
JASO (JA Solar Holdings Co., Ltd.)
Wednesday, November 15 2017 - 1:00pm
KLIC (Kulicke and Soffa Industries, Inc.)
Tuesday, November 14 2017 - 1:00pm
MSCC (Microsemi Corporation)
Thursday, November 9 2017 - 9:45pm
LPTH (LightPath Technologies, Inc.)
Thursday, November 9 2017 - 9:30pm
PXLW (Pixelworks, Inc.)
Tuesday, November 7 2017 - 10:00pm
LSCC (Lattice Semiconductor Corporation)
Tuesday, November 7 2017 - 10:00pm
KOPN (Kopin Corporation)
Tuesday, November 7 2017 - 1:30pm
MSI (Motorola Solutions, Inc.)
Thursday, November 2 2017 - 9:00pm
LPSN (LivePerson Inc.)
Wednesday, November 1 2017 - 9:00pm
CEVA (CEVA Inc.)
Wednesday, November 1 2017 - 12:30pm
IPGP (IPG Photonics Corporation)
Tuesday, October 31 2017 - 2:00pm
LECO (Lincoln Electric Holdings Inc.)
Friday, October 27 2017 - 2:00pm
MRK (Merck & Co. Inc.)
Friday, October 27 2017 - 12:00pm
CDNS (Cadence Design Systems Inc.)
Thursday, October 26 2017 - 9:00pm
LOGM (LogMeIn, Inc.)
Thursday, October 26 2017 - 9:00pm
CCMP (Cabot Microelectronics Corporation)
Thursday, October 26 2017 - 2:00pm

AlphaGraphics you may like